Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Videos

Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet

Articles

Survey responses indicate that bio/pharma faces tariff-driven rising costs and supply strain, with firms aiming to boost compliance and diversification and seeking stable trade and R&D support.

Bio/Pharma's Tariff Response: Key Insights from Industry Survey Results

Based on an analysis done by the European Medicines Agency on the feasibility of alternatives, the European Commission maintains use of titanium dioxide in drug products.

In Europe, the Use of Titanium Dioxide in Drugs Will Continue

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

New manufacturing methods are being explored, but challenges are still present in personalized medicine development.

Personalized and Patient-Centric Administration of Oral Medicines

Florian Schindler is head of Business Development, ACTEGA GmbH.

Thermoplastic elastomers (TPE) offer a PFAS-free solution for stoppers in parenteral packaging, ensuring a safer and more sustainable product.

Sustainable Alternative: PFAS-Free-TPE for Pharmaceutical Stoppers

Feliza Mirasol is the science editor for 

The company’s expanded label for Avtozma (tocilizumab-anoh) now includes the treatment of cytokine release syndrome, aligning the therapy with all indications for which Actemra is approved in the US.

FDA Grants Approval to Celltrion for Expanded Indication of Actemra Biosimilar to Treat CRS

Modular process design, single-use technologies, and flexible filling lines are some of the ways manufacturers can combat challenges involved in small-batch manufacturing.

Flexibility Provides Solutions to Small-Batch Manufacturing Challenges

Newly approved needle-free adrenaline spray offers longer shelf life, better stability, and easier use, signaling a shift in emergency drug delivery design.

UK Anaphylaxis Nasal Spray Approval Helps Reshape Emergency Allergy Treatment

Hydrogels, drug-eluting contact lenses, and other implant technologies show real promise.

Advanced Solutions for Sustained Delivery of Ocular Therapies

Cheryl Barton is director of PharmaVision, 

mRNA technologies offer great promise in immunotherapy and non-immunogenic applications.